PRAC, or Poly (ADP-ribose) polymerase (PARP) inhibitor, is a class of drugs that has shown significant promise in the treatment of cancer. These inhibitors target the PARP enzyme, which helps repair DNA damage in cells. By blocking PARP, these drugs aim to prevent cancer cells from repairing themselves, leading to cell death.
